Yüklüyor......
Scavenging Effects of Dexrazoxane on Free Radicals
Dexrazoxane (ICRF-187) has been clinically used to reduce doxorubicin-induced cardiotoxicity for more than 20 years. It has been proposed that dexrazoxane may act through its rings-opened hydrolysis product ADR-925, which can either remove iron from the iron-doxorubicin complex or bind to free iron,...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
the Society for Free Radical Research Japan
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2966934/ https://ncbi.nlm.nih.gov/pubmed/21103033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3164/jcbn.10-64 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|